| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51c002d89caa6c2aa2e6b4e546fac154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6a7f5c0b88fb21a7edd865efd5824bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b502fde933db1d6126d10bbcbddb83ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9951ccb7d24b60632b65f5fa7f623af6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b42624b9a1f2369ca887d7a28c91d54a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-782 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-466
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-645
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-375 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 |
| filingDate |
2000-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e2bda88a461bdca60b6e92ea3b6fef3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5cdc1c095082d69d3d5b3a44db7be08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea0244ada4ad1b57b2583e6e4f5de1c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc185e935bdaf65332357dcc4fddbd36 |
| publicationDate |
2002-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0128536-A3 |
| titleOfInvention |
Use of compositions for the caring treatment of the skin |
| abstract |
The invention relates to the use of compositions which represent a promising potential for the topical treatment of dry skin. Said compositions contain inhibitors in a physiologically compatible carrier which can be distributed on the skin. The inhibitors are used for the proteases that participate in the desmosome decomposition. The inhibitors contribute significantly to reduce desquamation processes and thus improve the appearance of the skin. Useful inhibitors can be boric acid and the derivatives thereof, 4-(2-amino-ethyl)phenyl sulfonyl fluoride (Pefabloc® and Pefabloc® SC), the pentapeptide sequence glycine-proline-phenylalanine-proline-leucine and the derivatives which contain said pentapeptide sequence, as well as rosemary acid and the active agent Elhibin® which is obtained from the leguminose seeds. |
| priorityDate |
1999-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |